Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.
Mitsiades CS, Negri J, McMullan C, McMillin DW, Sozopoulos E, Fanourakis G, Voutsinas G, Tseleni-Balafouta S, Poulaki V, Batt D, Mitsiades N.
Mitsiades CS, et al. Among authors: mitsiades n.
Mol Cancer Ther. 2007 Mar;6(3):1070-8. doi: 10.1158/1535-7163.MCT-06-0449.
Mol Cancer Ther. 2007.
PMID: 17363500